Company Data
Travere Therapeutics Inc.
Ticker
TVTX
Current Price
$17.5 -1.13%
Market Cap
$1.6B
Price Target
Refer to Report
Volume
1.8M
52wk Range
$8.83 - $25.29
Overview
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) – rare kidney disorders that often lead to end-stage kidney disease.